CD147 expression was found in 112 out of 129 tumor entities with the following incidences: squamous cell carcinomas (60–100%), pancreatic cancer (87%), chromophobic kidney cancer (83%), hepatocellular carcinoma (83%), medullary breast cancer (83%), and glioblastoma multiforme (79%). Here, BSG is linked to pancreatic neoplasm.